Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probing Cannabinoid System in Psychosis Family History
NCT02102113Phase 1Active, not recruiting
- Sponsor
- Yale University
- Start
- Jan 2014
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial (2 arms), sponsored by Yale University. Primary endpoint: Positive and Negative Symptom Scale. Started Jan 2014; status: active, not recruiting.
Beyond the preview
Go deeper on NCT02102113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02102113.